Literature DB >> 6424464

Prophylaxis of infection in patients with aplastic anemia receiving allogeneic marrow transplants.

R M Navari, C D Buckner, R A Clift, R Storb, J E Sanders, P Stewart, K M Sullivan, B Williams, G W Counts, J D Meyers.   

Abstract

One hundred one patients with severe aplastic anemia underwent allogeneic marrow transplantation and received one of three forms of infection prophylaxis: oral nonabsorbable antibiotics and isolation and decontamination in a laminar airflow room (36 patients); prophylactic granulocyte transfusions from a single family member donor (33 patients); or conventional treatment in single rooms with hand-washing and mask precautions (31 patients). During the period of granulocytopenia, patients in the laminar airflow rooms acquired fewer infections than either of the other groups, but this difference was statistically significant only when compared with the group receiving conventional treatment. Patients in the laminar airflow rooms had significantly fewer infections after engraftment as compared with the other two groups. Incidence of interstitial pneumonia and graft rejection was not different among the three groups. Acute graft-versus-host disease occurred later (Day 47) in the group in the laminar airflow rooms as compared with the group receiving prophylactic granulocyte transfusions (Day 23) or the group receiving conventional treatment (Day 20). The incidence of grades II to IV acute graft-versus-host disease was less in the patients in the laminar airflow rooms but only reached borderline significance (p = 0.08) when compared with the conventionally treated patients. The survival at Day 100 was 92 percent for the group in the laminar airflow rooms, 79 percent for the group receiving prophylactic granulocyte transfusions, and 64 percent for the group receiving conventional treatment.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6424464     DOI: 10.1016/0002-9343(84)90274-2

Source DB:  PubMed          Journal:  Am J Med        ISSN: 0002-9343            Impact factor:   4.965


  12 in total

Review 1.  Microbiota Manipulation With Prebiotics and Probiotics in Patients Undergoing Stem Cell Transplantation.

Authors:  Tessa M Andermann; Andrew Rezvani; Ami S Bhatt
Journal:  Curr Hematol Malig Rep       Date:  2016-02       Impact factor: 3.952

2.  Prevention of infection and graft-versus-host disease by suppression of intestinal microflora in children treated with allogeneic bone marrow transplantation.

Authors:  J M Vossen; P J Heidt; H van den Berg; E J Gerritsen; J Hermans; L J Dooren
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1990-01       Impact factor: 3.267

Review 3.  Intestinal microbiota-related effects on graft-versus-host disease.

Authors:  Yusuke Shono; Melissa D Docampo; Jonathan U Peled; Suelen M Perobelli; Robert R Jenq
Journal:  Int J Hematol       Date:  2015-03-27       Impact factor: 2.490

4.  Laminar air flow isolation and decontamination: a prospective randomized study of the effects of prophylactic systemic antibiotics in bone marrow transplant patients.

Authors:  F B Petersen; C D Buckner; R A Clift; S Lee; N Nelson; G W Counts; J D Meyers; J E Sanders; P S Stewart; W I Bensinger
Journal:  Infection       Date:  1986 May-Jun       Impact factor: 3.553

Review 5.  The gut microbiota and graft-versus-host disease.

Authors:  David N Fredricks
Journal:  J Clin Invest       Date:  2019-05-01       Impact factor: 14.808

6.  The effects of infection prevention regimens on early infectious complications in marrow transplant patients: a four arm randomized study.

Authors:  F Petersen; M Thornquist; C Buckner; G Counts; N Nelson; J Meyers; R Clift; E Thomas
Journal:  Infection       Date:  1988 Jul-Aug       Impact factor: 3.553

7.  Infectious complications after allogeneic bone marrow transplantation with and without T-cell depletion of donor marrow.

Authors:  T Schmeiser; M Wiesneth; D Bunjes; R Arnold; B Hertenstein; W Heit; E Kurrle
Journal:  Infection       Date:  1989 May-Jun       Impact factor: 3.553

8.  Glutamine-enriched intravenous feedings attenuate extracellular fluid expansion after a standard stress.

Authors:  M R Scheltinga; L S Young; K Benfell; R L Bye; T R Ziegler; A A Santos; J H Antin; P R Schloerb; D W Wilmore
Journal:  Ann Surg       Date:  1991-10       Impact factor: 12.969

9.  Antimicrobial prophylaxis in neutropenic patients after bone marrow transplantation.

Authors:  T Schmeiser; E Kurrle; R Arnold; D Krieger; W Heit; H Heimpel
Journal:  Infection       Date:  1988       Impact factor: 3.553

Review 10.  The Microbiome and Hematopoietic Cell Transplantation: Past, Present, and Future.

Authors:  Tessa M Andermann; Jonathan U Peled; Christine Ho; Pavan Reddy; Marcie Riches; Rainer Storb; Takanori Teshima; Marcel R M van den Brink; Amin Alousi; Sophia Balderman; Patrizia Chiusolo; William B Clark; Ernst Holler; Alan Howard; Leslie S Kean; Andrew Y Koh; Philip L McCarthy; John M McCarty; Mohamad Mohty; Ryotaro Nakamura; Katy Rezvani; Brahm H Segal; Bronwen E Shaw; Elizabeth J Shpall; Anthony D Sung; Daniela Weber; Jennifer Whangbo; John R Wingard; William A Wood; Miguel-Angel Perales; Robert R Jenq; Ami S Bhatt
Journal:  Biol Blood Marrow Transplant       Date:  2018-02-19       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.